close :

:

Forgotten your password?
 
New Drug Applications
Printable Version   Email to a friend

Ionsys

fentanyl

Treatment for Pain

ALZA Corporation Receives Approvable Letter Regarding IONSYS, an Iontophoretic, Fentanyl-containing, Transdermal Analgesic

MOUNTAIN VIEW, Calif., July 27, 2004 -- ALZA Corporation today announced it has received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding a New Drug Application (NDA) for IONSYS.

ALZA submitted a NDA for IONSYS in September 2003. It is working with the FDA to address the agency's letter as quickly as possible.

ALZA Corporation, a member of the Johnson & Johnson family of companies, is a leading developer of drug delivery-based pharmaceutical products.

for further information, please visit www.alza.com




Related Articles:

ALZA Corporation Resubmits U.S. New Drug Application for IONSYS (Fentanyl HCl Patient-Activated Transdermal System) - November 28, 2005

Latest New Drug Applications...

New Drug Applications Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec

More News Resources


Join Drugs.com
Click here to see what benefits you can get by joining our FREE membership programme.
Drugs.com is the most popular, comprehensive, and up-to-date source of drug information online. Providing advice on more than 24,000 prescription drugs and over-the-counter medicines for consumers and professionals .
Advertisement
In The Pipeline